Dronabinol Market size was valued at USD 123 Million in 2024 and is projected to reach USD 400 Million by 2033, exhibiting a CAGR of 15.5% from 2026 to 2033.
South Korea's medical cannabis landscape is evolving, with Dronabinol—synthetic THC—emerging as a pivotal component in therapeutic treatments. As of 2025, the medical cannabis market in South Korea is projected to reach approximately USD 284.40 million, with expectations of steady growth in the coming years. citeturn0search4
**Regulatory Framework and Medical Use**
In 2018, South Korea became the first East Asian nation to legalize medical cannabis, allowing patients with specific conditions such as epilepsy, cancer, and HIV/AIDS to access cannabis-based treatments. However, the use of Dronabinol is subject to stringent regulations. Patients must obtain approval from the Ministry of Food and Drug Safety (MFDS), providing comprehensive medical documentation and demonstrating that alternative treatments are ineffective. This rigorous approval process ensures that Dronabinol is prescribed responsibly and remains a controlled substance within the country. citeturn0search3
**Industry Demand and Market Dynamics**
The demand for Dronabinol in South Korea is primarily driven by its efficacy in managing chemotherapy-induced nausea, chronic pain, and spasticity associated with multiple sclerosis. Despite its therapeutic potential, the market faces challenges, including high costs and limited insurance coverage, which can restrict patient access. Additionally, the stigma surrounding cannabis use contributes to a cautious approach among healthcare providers and patients alike.
**Recent Regulatory Developments**
In June 2024, the MFDS amended regulations to prohibit the use of terms like THC and CBD in the labeling and advertising of food products. This move aims to prevent consumer confusion and curb deceptive marketing practices, reflecting the government's commitment to stringent control over cannabis-related substances. citeturn0search0
**Future Outlook**
Looking ahead, the South Korean medical cannabis market, including Dronabinol, is expected to experience gradual growth. Projections indicate a compound annual growth rate (CAGR) of 3.61% from 2025 to 2029, potentially reaching a market volume of USD 327.80 million by 2029. This growth is contingent upon evolving regulatory policies, increased patient awareness, and broader acceptance within the medical community. citeturn0search4
In summary, while Dronabinol holds promise for patients with specific medical conditions, its integration into South Korea's healthcare system is shaped by a complex interplay of regulatory oversight, industry demand, and societal perceptions. As policies continue to evolve, stakeholders must navigate these factors to optimize the therapeutic benefits of Dronabinol for those in need.
Get an In-Depth Research Analysis of the South Korea Dronabinol Market Size And Forecast [2025-2032]
Canopy Growth
Noramco
KinetoChem
Entourage Phytolab
THC Pharm
Echo Pharmaceuticals
BOL Pharma
Aphios Corporation
Benuvia Manufacturing
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Dronabinol Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Dronabinol Market
Capsules
Oral Solutions
Oils and Tinctures
Injectable Forms
Chronic Pain Management
Nausea and Vomiting Control
Anorexia Treatment
Neuropathic Pain Relief
Age Groups
Gender
Health Status
Pharmacies
Hospitals and Clinics
Specialized Health Stores
Prescription-based Dronabinol
Over-the-Counter Products
Clinical Trial-based Variants
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Dronabinol Market Research Analysis
1. Introduction of the South Korea Dronabinol Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Dronabinol Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Dronabinol Market, By Type
6. South Korea Dronabinol Market, By Application
7. South Korea Dronabinol Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Dronabinol Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/